. The purported beneﬁts of surveillance in this setting are similar
to those after lower extremity bypass, but it is noteworthy
that surveillance after lower extremity bypass has not
been shown to be effective in a well-performed randomized trial162 nor supported in the Trans-Atlantic Inter-Society Consensus II recommendations.163 Schoch et al164
reported that 83% of the patients undergoing endovascular treatment for CMI (n ¼ 